Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01168427 · ClinicalTrials.gov registry record
Reveal In-Office Implants
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 66
- Enrollment target
NCT01168427: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT01168427 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01168427 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to gather evidence about the safety and feasibility of performing the implant procedure for the Reveal Insertable Cardiac Monitor (ICM) in an office or clinic setting rather than the traditional hospital operating room, cardiac catheterization or electrophysiology (EP) laboratory setting.
Primary Outcome
This objective estimates the proportion of patients having procedure-related complication requiring resolution by surgical intervention at 90 days post-implant procedure using Kaplan-Meier method.
Interventions
- DEVICE Reveal® DX or Reveal® XT Insertable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-05 |
What the finished NCT01168427 record still lists
NCT01168427 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Reveal® DX or Reveal® XT Insertable Cardiac Monitor is the first listed.
NCT01168427 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01168427 about?
NCT01168427 is a clinical study titled "Reveal In-Office Implants". The purpose of this study is to gather evidence about the safety and feasibility of performing the implant procedure for the Reveal Insertable Cardiac Monitor (ICM) in an office or clinic setting rather than the traditional hospital operating room, cardiac catheterization or electrophysiology (EP) l...
What is the current status of trial NCT01168427?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2010-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01168427?
The interventions under investigation include: Reveal® DX or Reveal® XT Insertable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT01168427?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia